chronic inflammatory demyelinating polyneuropathy (cidP) is the most common acquired immune-mediated inflammatory disorder of the peripheral nervous system. The diagnosis is based in classic cases, on the distribution pattern of the neurological semiology and pathological changes of nerve conduction studies (NcS). however, in cases with subtle clinical presentation, an extended diagnostic workup may be needed (cerebrospinal fluid examination, laboratory tests, nerve biopsy). NcS remain fundamental for the diagnosis, follow-up and measurement of response to immunetreatment in cidP. however, new challenges arose on how best to acquire a static and dynamic imaging of the peripheral nerves, with the aim of providing a holistic approach to the nerve impairment. according to the literature, neuromuscular ultrasound is able to detect in cases of cidP thickened or swollen roots, peripheral nerves or brachial plexus, findings that are consistent with ongoing inflammation. This review provides a timely update on the nerve ultrasound findings of cidP and future possibilities of neuromuscular ultrasound are also discussed.
chronic inflammatory demyelinating polyneuropathy (cidP) is an acquired immune-mediated inflammatory disorder of the peripheral nervous system with an estimated prevalence of about 0.5 per 100,000 children and 1 to 2 per 100,000 adults. 1, 2 Typical cidP arises between the ages of 30 and 60 years and is characterised from a progressive, symmetric proximal and distal muscle weakness, paresthesias, sensory dysfunction, impaired balance and reduced or diminished tendon reflexes which evolve slowly over at least 8 weeks. The course can be either monophasic with stepwise progression or relapsing with spontaneous remissions. 3 The diagnosis is based, in typical cases, on the time course, distribution pattern of nerve impairment and results of the nerve conduction studies (NcS), that are frequently consistent with a motor and sensory demyelinating polyradiculoneuropathy, with evidence of conduction block and temporal dispersion. 4, 5 These findings may be further supported from evidence of cytoalbuminologic dissociation in cerebrospinal fluid analysis, but this is not obligatory for the diagnosis. 6 different criteria, such as inflammatory Neuropathy cause and Treatment (iNcaT), american academy of Neurology (aaN) and Saperstein, can be used to define the disease. 7, 8 While the NcS remain nowadays fundamental to confirm the presence, pattern and severity of this type of polyradiculoneuropathy, 6 new challenges arose in the last few years, how to acquire the best static and dynamic imaging of the relevant nerve structures in cidP, aiming to provide a complementary and holistic approach to nerve impairment. maximal cross sectional area of the brachial plexus / minimal cross sectional area of the brachial plexus (see Table 1 ). 
Ultrasound Findings
currently ten studies (evaluating a total of 74 cases) on nerve sonography in cidP patients have been published (see Table 2 ). The first description of the sonographic findings in cidP was published from Taniguchi et al. 33, [39] [40] although this seemed to be a promising development, it is worth noting that Zaidman et al. failed to confirm these findings in a later study. 15 Systematic studies on the sensitivity and specificity of this finding failed in the literature. a novel approach to the quantification of the pathological acquired demyelinating sensory and motor neuropathy (MadSaM). 20, 21 Systematic data on the sensitivity and specificity of sonography as a screening method of immune therapy do not exist. 
Conclusions

